266
Views
1
CrossRef citations to date
0
Altmetric
CLINICAL TRIAL REPORT

Cytokine Patterns as Predictors of Antibiotic Treatment Effect in Chronic Low Back Pain with Modic Changes: Subgroup Analyses of a Randomized Trial (AIM Study)

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1713-1724 | Received 16 Feb 2023, Accepted 21 Apr 2023, Published online: 23 May 2023

References

  • Modic MT, Steinberg PM, Ross JS, Masaryk TJ, Carter JR. Degenerative disk disease: assessment of changes in vertebral body marrow with MR imaging. Radiology. 1988;166(1 Pt 1):193. doi:10.1148/radiology.166.1.3336678
  • Dudli S, Liebenberg E, Magnitsky S, Lu B, Lauricella M, Lotz JC. Modic type 1 change is an autoimmune response that requires a proinflammatory milieu provided by the “Modic disc”. Spine J. 2018;18(5):831–844. doi:10.1016/j.spinee.2017.12.004
  • Bobechko W, Hirsch C. Auto-immune response to nucleus pulposus in the rabbit. J Bone Joint Surg Br. 1965;47(3):574–580. doi:10.1302/0301-620X.47B3.574
  • Geiss A, Larsson K, Junevik K, Rydevik B, Olmarker K. Autologous nucleus pulposus primes T cells to develop into interleukin‐4‐producing effector cells: an experimental study on the autoimmune properties of nucleus pulposus. J Orthopaed Res. 2009;27(1):97–103. doi:10.1002/jor.20691
  • Gertzbein S, Tait J, Devlin S. The stimulation of lymphocytes by nucleus pulposus in patients with degenerative disk disease of the lumbar spine. Clin Orthop Relat Res. 1977;123:149–154.
  • Capoor MN, Konieczna A, McDowell A, et al. Pro-inflammatory and neurotrophic factor responses of cells derived from degenerative human intervertebral discs to the opportunistic pathogen Cutibacterium acnes. Int J Mol Sci. 2021;22(5):2347. doi:10.3390/ijms22052347
  • Adams MA, Freeman BJ, Morrison HP, Nelson IW, Dolan P. Mechanical initiation of intervertebral disc degeneration. Spine. 2000;25(13):1625–1636. doi:10.1097/00007632-200007010-00005
  • Capoor M, Ruzicka F, Machackova T, et al. Prevalence of propionibacterium acnes in intervertebral discs of patients undergoing lumbar microdiscectomy: a prospective cross-sectional study. PLoS One. 2016;11(8):e0161676. doi:10.1371/journal.pone.0161676
  • Capoor MN, Ruzicka F, Schmitz JE, et al. Propionibacterium acnes biofilm is present in intervertebral discs of patients undergoing microdiscectomy. PLoS One. 2017;12(4):e0174518. doi:10.1371/journal.pone.0174518
  • Chen Z, Zheng Y, Yuan Y, et al. Modic changes and disc degeneration caused by inoculation of Propionibacterium acnes inside intervertebral discs of rabbits: a pilot study. Biomed Res Int. 2016;2016:9612437. doi:10.1155/2016/9612437
  • Dudli S, Liebenberg E, Magnitsky S, Miller S, Demir-Deviren S, Lotz JC. Propionibacterium acnes infected intervertebral discs cause vertebral bone marrow lesions consistent with Modic changes. J Orthopaed Res. 2016;34:1447–1455. doi:10.1002/jor.23265
  • Rajasekaran S, Tangavel C, Aiyer SN, et al. Is infection the possible initiator of disc disease? An insight from proteomic analysis. Eur Spine J. 2017;26:1384–1400. doi:10.1007/s00586-017-4972-3
  • Urquhart DM, Zheng Y, Cheng AC, et al. Could low grade bacterial infection contribute to low back pain? A systematic review. BMC Med. 2015;13:13. doi:10.1186/s12916-015-0267-x
  • Li B, Dong Z, Wu Y, et al. Association between lumbar disc degeneration and Propionibacterium acnes infection: clinical research and preliminary exploration of animal experiment. Spine. 2016;41(13):E764. doi:10.1097/BRS.0000000000001383
  • Benoist M. The Michel Benoist and Robert Mulholland yearly European Spine Journal review: a survey of the “medical” articles in the European Spine Journal, 2018. Eur Spine J. 2019;28(1):10–20. doi:10.1007/s00586-018-5857-9
  • Capoor MN, Birkenmaier C, Wang JC, et al. A review of microscopy-based evidence for the association of Propionibacterium acnes biofilms in degenerative disc disease and other diseased human tissue. Eur Spine J. 2019;28(12):2951–2971. doi:10.1007/s00586-019-06086-y
  • Albert HB, Sorensen JS, Christensen BS, Manniche C. Antibiotic treatment in patients with chronic low back pain and vertebral bone edema (Modic type 1 changes): a double-blind randomized clinical controlled trial of efficacy. Eur Spine J. 2013;22(4):697–707.
  • Bråten LCH, Rolfsen MP, Espeland A, et al. Efficacy of antibiotic treatment in patients with chronic low back pain and Modic changes (the AIM study): double blind, randomised, placebo controlled, multicentre trial. BMJ. 2019;367:l5654. doi:10.1136/bmj.l5654
  • Bråten LCH, Grøvle L, Espeland A, et al. Clinical effect modifiers of antibiotic treatment in patients with chronic low back pain and Modic changes-secondary analyses of a randomised, placebo-controlled trial (the AIM study). BMC Musculoskelet Disord. 2020;21(1):1–11. doi:10.1186/s12891-020-03422-y
  • Kristoffersen PM, Bråten LC, Vetti N, et al. Oedema on STIR modified the effect of amoxicillin as treatment for chronic low back pain with Modic changes—subgroup analysis of a randomized trial. Eur Radiol. 2021;31(6):4285–4297. doi:10.1007/s00330-020-07542-w
  • Heggli I, Schüpbach R, Herger N, et al. OP0083 Infectious and Autoinflammatory Modic Type 1 Changes Have Different Pathomechanisms. BMJ Publishing Group Ltd; 2021.
  • Schirmer M, Kumar V, Netea MG, Xavier RJ. The causes and consequences of variation in human cytokine production in health. Curr Opin Immunol. 2018;54:50–58. doi:10.1016/j.coi.2018.05.012
  • Risbud MV, Shapiro IM. Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol. 2014;10(1):44–56. doi:10.1038/nrrheum.2013.160
  • Dudli S, Fields AJ, Samartzis D, Karppinen J, Lotz JC. Pathobiology of Modic changes. Eur Spine J. 2016;25(11):3723–3734. doi:10.1007/s00586-016-4459-7
  • Dudli S, Miller S, Demir-Deviren S, Lotz JC. Inflammatory response of disc cells against Propionibacterium acnes depends on the presence of lumbar Modic changes. Eur Spine J. 2018;27(5):1013–1020. doi:10.1007/s00586-017-5291-4
  • Turner MD, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochimica et Biophysica Acta (BBA). 2014;1843(11):2563–2582.
  • Gjefsen E, Gervin K, Goll G, et al. Macrophage migration inhibitory factor: a potential biomarker for chronic low back pain in patients with Modic changes. RMD Open. 2021;7(2):e001726. doi:10.1136/rmdopen-2021-001726
  • Altan-Bonnet G, Mukherjee R. Cytokine-mediated communication: a quantitative appraisal of immune complexity. Nat Rev Immunol. 2019;19(4):205–217. doi:10.1038/s41577-019-0131-x
  • Kothur K, Wienholt L, Mohammad SS, et al. Utility of CSF cytokine/chemokines as markers of active intrathecal inflammation: comparison of demyelinating, anti-NMDAR and enteroviral encephalitis. PLoS One. 2016;11(8):e0161656. doi:10.1371/journal.pone.0161656
  • Michael BD, Griffiths MJ, Granerod J, et al. Characteristic cytokine and chemokine profiles in encephalitis of infectious, immune-mediated, and unknown aetiology. PLoS One. 2016;11(1):e0146288. doi:10.1371/journal.pone.0146288
  • Kothur K, Bandodkar S, Wienholt L, et al. Etiology is the key determinant of neuroinflammation in epilepsy: elevation of cerebrospinal fluid cytokines and chemokines in febrile infection‐related epilepsy syndrome and febrile status epilepticus. Epilepsia. 2019;60(8):1678–1688. doi:10.1111/epi.16275
  • Kyogoku C, Smiljanovic B, Grün JR, et al. Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference? PLoS One. 2013;8(12):e83776. doi:10.1371/journal.pone.0083776
  • Yeung W-CG, Al-Shabeeb A, Pang CNI, et al. Children with islet autoimmunity and enterovirus infection demonstrate a distinct cytokine profile. Diabetes. 2012;61(6):1500–1508. doi:10.2337/db11-0264
  • Brinkmann J, Zeißler E-C, Scharrenberg JS, et al. The diagnostic value of cytokines for the discrimination of vertebral osteomyelitis and degenerative diseases of the spine. Cytokine. 2022;150:155782. doi:10.1016/j.cyto.2021.155782
  • Yu Y, Champer J, Agak GW, Kao S, Modlin RL, Kim J. Different Propionibacterium acnes phylotypes induce distinct immune responses and express unique surface and secreted proteomes. J Investig Dermatol. 2016;136(11):2221–2228. doi:10.1016/j.jid.2016.06.615
  • Yuan Y, Chen Y, Zhou Z, et al. Association between chronic inflammation and latent infection of Propionibacterium acnes in non-pyogenic degenerated intervertebral discs: a pilot study. Eur Spine J. 2018;27(10):2506–2517. doi:10.1007/s00586-017-5363-5
  • Jiao Y, Yuan Y, Lin Y, et al. Propionibacterium acnes induces discogenic low back pain via stimulating nucleus pulposus cells to secrete pro-algesic factor of IL-8/CINC-1 through TLR2–NF-κB p65 pathway. J Mol Med. 2019;97(1):25–35. doi:10.1007/s00109-018-1712-z
  • Schmid B, Hausmann O, Hitzl W, Achermann Y, Wuertz-Kozak K. The role of Cutibacterium acnes in intervertebral disc inflammation. Biomedicines. 2020;8(7):186. doi:10.3390/biomedicines8070186
  • Romics JL, Dolganiuc A, Velayudham A, et al. Toll‐like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni‐bacterium acnes. J Leukoc Biol. 2005;78(6):1255–1264. doi:10.1189/jlb.0804448
  • Basal E, Jain A, Kaushal G. Antibody response to crude cell lysate of propionibacterium acnes and induction of pro-inflammatory cytokines in patients with acne and normal healthy subjects. J Microbiol. 2004;42(2):117–125.
  • Di Cesare PE, Chang E, Preston CF, Liu C-J. Serum interleukin-6 as a marker of periprosthetic infection following total Hip and knee arthroplasty. JBJS. 2005;87(9):1921–1927. doi:10.2106/00004623-200509000-00003
  • Ugge H, Carlsson J, Söderquist B, Fall K, Andén O, Davidsson S. The influence of prostatic Cutibacterium acnes infection on serum levels of IL6 and CXCL8 in prostate cancer patients. Infect Agent Cancer. 2018;13(1):34. doi:10.1186/s13027-018-0204-7
  • Bråten LC, Gervin K, Pripp AH, et al. Statistical analysis plan for analysis of cytokines as prognostic factors and predictors of antibiotic treatment effect in the AIM trial. 2021.
  • Grotle M, Vøllestad M, Brox M. Cross-cultural adaptation of the Norwegian versions of the Roland-Morris Disability Questionnaire and the Oswestry Disability Index. J Rehabil Med. 2003;35(5):241–247. doi:10.1080/16501970306094
  • Chiarotto A, Boers M, Deyo RA, et al. A core outcome measurement set for low back pain clinical trials. Orthopaed Proc. 2018;100-B(SUPP_2):29.
  • Fairbank JC, Pynsent PB. The Oswestry disability index. Spine. 2000;25(22):2940. doi:10.1097/00007632-200011150-00017
  • Dworkin HR, Turk CD, Farrar TJ, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113(12):9–19. doi:10.1016/j.pain.2004.09.012
  • Hingorani AD, van der Windt DA, Riley RD, et al. Prognosis research strategy (PROGRESS) 4: stratified medicine research. BMJ. 2013;346:125.
  • Lipkovich I, Dmitrienko A, D’Agostino B. Tutorial in biostatistics: data‐driven subgroup identification and analysis in clinical trials. Stat Med. 2017;36(1):136–196. doi:10.1002/sim.7064
  • Hiyama A, Suyama K, Sakai D, Tanaka M, Watanabe M. Correlational analysis of chemokine and inflammatory cytokine expression in the intervertebral disc and blood in patients with lumbar disc disease. J Orthopaed Res. 2022;40(5):1213–1222. doi:10.1002/jor.25136
  • Boisson M, Borderie D, Henrotin Y, et al. Serum biomarkers in people with chronic low back pain and Modic 1 changes: a case-control study. Sci Rep. 2019;9(1):1–5. doi:10.1038/s41598-019-46508-x
  • Gilligan CJ, Cohen SP, Fischetti VA, Hirsch JA, Czaplewski LG. Chronic Low Back Pain, bacterial infection and treatment with antibiotics. Spine J. 2021;21:903–914. doi:10.1016/j.spinee.2021.02.013
  • Ohrt‐Nissen S, Fritz BG, Walbom J, et al. Bacterial biofilms: a possible mechanism for chronic infection in patients with lumbar disc herniation–a prospective proof‐of‐concept study using fluorescence in situ hybridization. Apmis. 2018;126(5):440–447. doi:10.1111/apm.12841
  • Lingsma H, Roozenbeek B, Steyerberg E. Covariate adjustment increases statistical power in randomized controlled trials. J Clin Epidemiol. 2010;63(12):1391. doi:10.1016/j.jclinepi.2010.05.003
  • Vanelderen P, Van Zundert J, Kozicz T, et al. Effect of minocycline on lumbar radicular neuropathic pain: a randomized, placebo-controlled, double-blind clinical trial with amitriptyline as a comparator. Anesthesiology. 2015;122(2):399–406. doi:10.1097/ALN.0000000000000508
  • McNamara AL, Dickerson EC, Gomez-Hassan DM, Cinti SK, Srinivasan A. Yield of image-guided needle biopsy for infectious discitis: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2017;38(10):2021–2027. doi:10.3174/ajnr.A5337